266 related articles for article (PubMed ID: 16729010)
1. Drug insight: Statin use in the elderly.
Raffel OC; White HD
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
[TBL] [Abstract][Full Text] [Related]
2. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
Kvan E; Pettersen KI; Landmark K; Reikvam A;
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
[TBL] [Abstract][Full Text] [Related]
3. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S
Circulation; 2007 May; 115(18):2398-409. PubMed ID: 17452609
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?
van Hout BA; Simoons ML
Eur Heart J; 2001 May; 22(9):751-61. PubMed ID: 11350107
[TBL] [Abstract][Full Text] [Related]
5. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
6. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intensive statin therapy in the elderly.
Maroo BP; Lavie CJ; Milani RV
Am J Geriatr Cardiol; 2008; 17(2):92-100. PubMed ID: 18326948
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the role of statin therapy in reducing myocardial infarction following elective percutaneous coronary intervention.
Mood GR; Bavry AA; Roukoz H; Bhatt DL
Am J Cardiol; 2007 Sep; 100(6):919-23. PubMed ID: 17826370
[TBL] [Abstract][Full Text] [Related]
9. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
Kerst LL; Mauro VF
Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
[TBL] [Abstract][Full Text] [Related]
10. Early statin therapy in acute coronary syndromes.
Kinlay S
Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
[TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
13. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
14. Early statin therapy in acute coronary syndromes.
Kinlay S; Ganz P
Semin Vasc Med; 2003 Nov; 3(4):419-24. PubMed ID: 15199449
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoutilization of statin therapy after acute myocardial infarction. A real practice analysis based on administrative data.
Degli Esposti L; Di Martino M; Saragoni S; Valpiani G; Capone A; Corvi E; Degli Esposti E
Ital Heart J; 2004 Feb; 5(2):120-6. PubMed ID: 15086141
[TBL] [Abstract][Full Text] [Related]
16. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
17. Statins for cardiovascular prevention according to different strategies: a cost analysis.
Ito MK; Nanchen D; Rodondi N; Paccaud F; Waeber G; Vollenweider P; Marques-Vidal P
Am J Cardiovasc Drugs; 2011; 11(1):33-44. PubMed ID: 21265581
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
[TBL] [Abstract][Full Text] [Related]
19. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
Pöss J; Böhm M; Laufs U
Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
[TBL] [Abstract][Full Text] [Related]
20. Initiating statins in the elderly: the evolving challenge.
Walker DB; Jacobson TA
Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):182-7. PubMed ID: 18316955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
